Table 1 Demographic and clinical characteristics of the subjects
Nonsurvivors (n = 28) | Survivors (n = 250) | ||
|---|---|---|---|
Sex, male | 133 (47.8) | 11 (39.3) | 122 (48.8) |
Age (years) | 78 (71–83) | 79.5 (70.3–83.3) | 78 (75–83) |
Departure place for EDa) visit | |||
Home | 188 (67.6) | 18 (64.3) | 170 (68) |
Other medical centres | 70 (25.2) | 8 (28.6) | 62 (24.8) |
Nursing hospital or facility | 20 (7.2) | 2 (7.1) | 18 (7.2) |
Inability to ambulate | 50 (18) | 5 (35.7) | 45 (16.0) |
Medical history | |||
Diabetes mellitus | 105 (37.8) | 13 (46.4) | 92 (36.8) |
Hypertension | 177 (63.7) | 17 (60.7) | 160 (64.0) |
Coronary artery disease | 40 (14.4) | 4 (14.3) | 36 (14.4) |
Congestive heart failure | 24 (8.6) | 4 (14.3) | 20 (8.0) |
Chronic liver disease | 10 (3.6) | 0 (0) | 10 (4) |
Chronic renal disease | 37 (13.3) | 4 (14.3) | 33 (13.2) |
Chronic lung disease | 84 (30.2) | 11 (39.3) | 73 (29.2) |
Peptic ulcer disease | 9 (3.2) | 2 (7.1) | 7 (2.8) |
Arthritis | 76 (27.3) | 11 (39.3) | 65 (26.0) |
Charlson comorbidity index | 4 (4–5) | 4 (4–6) | 4 (4–5) |
Diagnosis of infectious diseases | |||
Respiratory | 124 (44.6) | 19 (67.9) | 105 (42.0%) |
Urinary tract | 59 (21.2) | 3 (10.7) | 56 (22.4) |
Gastrointestinal | 19 (6.8) | 3 (10.7) | 16 (6.4) |
Hepatobiliary | 41 (14.7) 9 (18.1) | 0 (0.0) | 41 (16.4) |
Soft tissue and musculoskeletal | 13 (4.6) | 3 (10.7) | 10 (4.0) |
Othersb) | 22 (7.9) | 0 (0.0) | 22 (8.8) |
Positive blood culture | 73 (26.3) | 10 (35.7) | 63 (25.2) |
Admission in Intensive Care Units (ICU) | 79 (28.4) | 20 (71.4) | 59 (23.6) |
Managements | |||
Intubation | 42 (15.1) | 18 (64.3) | 24 (9.6) |
Ventilator care | 40 (14.4) | 17 (60.7) | 23 (9.2) |
Central venous catheter | 53 (19.1) | 17 (60.7) | 36 (14.4) |
Vasopressor infusion | 61 (21.9) | 20 (71.4) | 41 (16.4) |
Septic shockc) | 38 (13.7) | 14 (50) | 24 (9.6) |
Length of stay in ICUd) (days) | 4 (2–8) | 3.5 (2.0–7.5) | 5 (3–9) |
Length of stay in hospital (days) | 10 (5–16) | 5 (2.8–13.3) | 10 (6–16) |